Eligard and Multiple myeloma - a phase IV clinical study of FDA data

Summary:

Multiple myeloma is reported as a side effect among people who take Eligard (leuprolide acetate), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Enzalutamide, and have High blood pressure.

The phase IV clinical study analyzes which people have Multiple myeloma when taking Eligard. It is created by eHealthMe based on reports of 44,585 people who have side effects when taking Eligard from the FDA, and is updated regularly.

What is Eligard?

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. eHealthMe is studying from 44,652 Eligard users. Check the latest studies of Eligard.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,109 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

On Jul, 14, 2026

44,585 people reported to have side effects when taking Eligard.
Among them, 22 people (0.05%) have Multiple myeloma.

Among these 22 people:

How long have people been on Eligard when they have Multiple myeloma? *

What is the gender of people who have Multiple myeloma when taking Eligard? *

female: 4.55 %
male: 95.45 %

What is the age of people who have Multiple myeloma when taking Eligard? *

What are other drugs people take besides Eligard? *

What are other side effects people have besides Multiple myeloma? *

Injection Site Mass: 3 people, 13.64%
Second Primary Malignancy (after getting cure a cancer, a new cancer development): 3 people, 13.64%
Death: 2 people, 9.09%
Localised Infection (infection at the single location): 2 people, 9.09%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 9.09%
Feeding Disorder (when children refuse to eat certain food groups): 2 people, 9.09%
Fatigue (feeling of tiredness): 2 people, 9.09%
Dehydration (dryness resulting from the removal of water): 2 people, 9.09%
Diarrhea: 2 people, 9.09%
Chronic Kidney Disease: 2 people, 9.09%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 18.18%
Osteoporosis (bones weak and more likely to break): 2 people, 9.09%
High Blood Cholesterol: 2 people, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.09%
Neoplasm Prostate (tumour of prostate): 1 person, 4.55%
Metastases To Bone (cancer spreads to bone): 1 person, 4.55%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 1 person, 4.55%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 4.55%
Dyslipidaemia (abnormal amount of lipids): 1 person, 4.55%
Cardiac Failure: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Eligard and have Multiple myeloma?

- Check whether Multiple myeloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eligard:

Eligard (44,652 reports)

Multiple myeloma treatments and more:

Multiple myeloma (516,725 reports)

Browse all side effects of Eligard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple myeloma:

Multiple myeloma (1,109 drugs)

Browse all the conditions that are associated with Multiple myeloma:

Multiple myeloma (1,404 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Eligard) and Eligard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.